Viewing Study NCT00093067

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-01-05 @ 2:52 PM
Study NCT ID: NCT00093067
Status: COMPLETED
Last Update Posted: 2017-02-13
First Post: 2004-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus
Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bacterial Endocarditis View
None Bacteremia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gram-positive bacterial infections View
None Staph Aureus View
None endocarditis View
None bacteremia View
None Cubist View